ARTICLE | Clinical News
LXN regulatory update
June 23, 1997 7:00 AM UTC
LXN received pre-market clearance from the FDA for its home version of a test for fructosamine levels, which it will market under the Gluco-Protein brand name. Fructosamine is produced by the reaction...